Alerts will be sent to your verified email
Verify EmailSYNCOMF
Syncom Formulations
|
Jagsonpal Pharma
|
Beta Drugs
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
8.81 % | 12.82 % | 21.73 % |
5yr average Equity Multiplier
|
1.5 | 1.29 | 1.75 |
5yr Average Asset Turnover Ratio
|
0.79 | 1.12 | 1.04 |
5yr Avg Net Profit Margin
|
7.78 % | 8.95 % | 11.97 % |
Price to Book
|
5.04 | 7.66 | 0.0 |
P/E
|
40.34 | 28.86 | 50.35 |
5yr Avg Cash Conversion Cycle
|
84.02 Days | -0.27 Days | 15.7 Days |
Inventory Days
|
27.61 Days | 47.66 Days | 43.83 Days |
Days Receivable
|
123.89 Days | 25.88 Days | 87.61 Days |
Days Payable
|
93.18 Days | 68.7 Days | 113.94 Days |
5yr Average Interest Coverage Ratio
|
39.83 | 56.07 | 13.71 |
5yr Avg ROCE
|
12.74 % | 17.0 % | 27.85 % |
5yr Avg Operating Profit Margin
|
9.47 % | 10.5 % | 21.58 % |
5 yr average Debt to Equity
|
0.2 | 0.02 | 0.23 |
5yr CAGR Net Profit
|
19.56 % | 23.34 % | 31.07 % |
5yr Average Return on Assets
|
5.89 % | 9.97 % | 12.53 % |
Shareholdings
|
|||
Promoter Holding
|
50.57 % | 67.78 % | 66.73 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
4.45 % | -0.93 % | 0.02 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Syncom Formulations
|
Jagsonpal Pharma
|
Beta Drugs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Raw Material Break-Up
|
Raw Material Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|